Loading clinical trials...
Loading clinical trials...
Chronic Wound Treatment With Extracellular Matrix (ECM) Scaffold Made From Fish Proteins
The clinical study is designed to assess the effectiveness, safety and non-immunogenicity of fish skin wound dressing extracellular matrix (ECM) in treating chronic wounds. The wound dressing is indicated for the management of difficult to heal and chronic wounds. The matrix is cut to fit the wound and is applied to the wound bed. An absorptive secondary dressing is put on top. Further dressing of the wound depends on the etiology. The indications for use are: * partial and full-thickness wounds * pressure ulcers * venous ulcers * diabetic ulcers * chronic vascular ulcers * tunneled/undermined wounds * trauma wounds (abrasions, lacerations, second-degree burns, and skin tears)
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
National University Hospital
Reykjavik, Iceland
Start Date
November 1, 2010
Primary Completion Date
December 1, 2012
Completion Date
January 1, 2013
Last Updated
March 3, 2017
37
ACTUAL participants
Marigen Wound Dressing
DEVICE
Lead Sponsor
Kerecis Ltd.
NCT07425418
NCT05496296
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06979037